Europeiska unionen - tjeckiska - EMA (European Medicines Agency)

accord healthcare s.l.u. - metformin hydrochloride, vildagliptin - diabetes mellitus, typ 2 - léky užívané při diabetu - vildagliptin/metformin hydrochloride accord is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:- in patients who are inadequately controlled with metformin hydrochloride alone. - in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. - in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 a 5. 1 pro dostupné údaje o různých kombinacích).

Europeiska unionen - tjeckiska - EMA (European Medicines Agency)

billev pharma aps - lutetium (177lu) chloride - radionuklidové zobrazování - terapeutické radiofarmaky - lutetium (177lu) chloride billev is a radiopharmaceutical precursor, and it is not intended for direct use in patients. it is to be used only for the radiolabelling of carrier molecules that have been specifically developed and authorised for radiolabelling with lutetium (177lu) chloride.

Europeiska unionen - tjeckiska - EMA (European Medicines Agency)

sun pharmaceutical industries europe b.v. - sitagliptin fumarate, metformin hydrochloride - diabetes mellitus, typ 2 - léky užívané při diabetu - for adult patients with type 2 diabetes mellitus:sitagliptin/metformin hydrochloride sun is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. sitagliptin/metformin hydrochloride sun is indicated in combination with a sulphonylurea (i. trojkombinační léčbě) jako doplněk k dietním opatřením a cvičení u pacientů nedostatečně maximální tolerované dávky metforminu a sulfonylmočoviny. sitagliptin/metformin hydrochloride sun is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparγ agonist. sitagliptin/metformin hydrochloride sun is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.

Tjeckien - tjeckiska - SUKL (Státní ústav pro kontrolu léčiv)

imuna pharm, a.s., Šarišské michaľany array - 1322 chlorid sodnÝ - infuzní roztok - 9mg/ml - elektrolyty

Tjeckien - tjeckiska - SUKL (Státní ústav pro kontrolu léčiv)

imuna pharm, a.s., Šarišské michaľany array - 1322 chlorid sodnÝ; 4957 monohydrÁt glukosy - infuzní roztok - 4,5mg/ml+25mg/ml - elektrolyty se sacharidy

Tjeckien - tjeckiska - SUKL (Státní ústav pro kontrolu léčiv)

ardeapharma, a.s., Ševětín array - 1202 prokain-hydrochlorid - injekční roztok - 0,2% - prokain

Tjeckien - tjeckiska - SUKL (Státní ústav pro kontrolu léčiv)

ardeapharma, a.s., Ševětín array - 1202 prokain-hydrochlorid - injekční roztok - 0,5% - prokain

Tjeckien - tjeckiska - SUKL (Státní ústav pro kontrolu léčiv)

ardeapharma, a.s., Ševětín array - 1489 trimekain-hydrochlorid - injekční roztok - 0,5% - amidy

Tjeckien - tjeckiska - SUKL (Státní ústav pro kontrolu léčiv)

ardeapharma, a.s., Ševětín array - 1489 trimekain-hydrochlorid - injekční roztok - 1% - amidy

Tjeckien - tjeckiska - SUKL (Státní ústav pro kontrolu léčiv)

biomedica, spol. s r.o., praha array - 1322 chlorid sodnÝ - infuzní roztok - 9mg/ml - elektrolyty